Cipla

Cipla Limited
Cipla
FormerlyChemical Industrial & Pharmaceutical Laboratories Ltd. (1935–1984)
Company typePublic
BSE500087
NSECIPLA
NSE NIFTY 50 constituent
ISININE059A01026
IndustryPharmaceuticals
Founded1935 (89 years ago) (1935)
FounderKhwaja Abdul Hamied
HeadquartersMumbai, Maharashtra, India
Area served
Worldwide
Key people
Products
RevenueIncrease 25,455 crore (US$3.0 billion) (FY24)[1]
Increase 6,233 crore (US$750 million) (FY24)[1]
Increase 4,106 crore (US$490 million) (FY24)[1]
Total assetsIncrease 32,511 crore (US$3.9 billion) (FY24)[1]
Total equityIncrease 26,706 crore (US$3.2 billion) (FY24)[1]
Number of employees
22,036[2]
SubsidiariesInvagen Pharmaceuticals
Websitewww.cipla.com

Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions.[3] Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.[4][5]

  1. ^ a b c d e "Q4 FY24 Investor Presentation" (PDF). Cipla. Retrieved 19 May 2024.
  2. ^ "Business Responsibility Report 2013-14" (PDF). Cipla. 15 July 2014. Archived from the original (PDF) on 17 March 2015. Retrieved 17 September 2014.
  3. ^ "Know 10 largest Pharmaceutical Companies in India". Edu Dwar. Retrieved 28 July 2023.
  4. ^ "Cipla betting big on digitisation and emerging segments". The Economic Times. Retrieved 6 December 2022.
  5. ^ "Cipla betting big on digitisation and emerging segments". Financial Express. Retrieved 6 December 2022.